The Evidence for Contraceptive options and HIV Outcomes (ECHO) Trial was a multicenter, open label, randomized clinical trial comparing HIV incidence and contraceptive benefits in women using depot medroxyprogesterone acetate (DMPA-IM), levonorgestrel (LNG) implants, and copper intrauterine devices (IUD). FHI 360 Study #523201